Alexander S. Hahn

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann, Prerna Arora, Rüdiger Groß et al. · Cell · 2021 · 1K citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation

Bojan F. Hörnich, Anna K. Großkopf, Sarah Schlagowski et al. · Journal of Virology · 2021 · 116 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination

Markus Hoffmann, Prerna Arora, Rüdiger Groß et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 64 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus

Anna K. Großkopf, Sarah Schlagowski, Bojan F. Hörnich et al. · Journal of Virology · 2019 · 44 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

A conserved Eph family receptor-binding motif on the gH/gL complex of Kaposi’s sarcoma-associated herpesvirus and rhesus monkey rhadinovirus

Anna K. Großkopf, Armin Ensser, Frank Neipel et al. · PLoS Pathogens · 2018 · 38 citations · Full text

Life Sciences, Molecular Biology, Oncology +17